Clinical Trials Logo

Dual-target CAR-T Cells clinical trials

View clinical trials related to Dual-target CAR-T Cells.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04723914 Recruiting - Lymphoma, B-Cell Clinical Trials

Dual Target CAR-T Cells in B-cell Lymphoma

CAR-T
Start date: October 20, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

Prospectively evaluate the safety and effectiveness of CD19/CD20 dual-target CAR-T cells in the treatment of relapsed/refractory B-cell lymphoma .

NCT ID: NCT04723901 Recruiting - Relapse Clinical Trials

Dual Target CAR-T Cells in B-cell Acute Lymphoblastic Leukemia

CAR-T
Start date: October 20, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

Prospectively evaluate the safety and effectiveness of CD19/CD22 dual-target CAR-T cells in the treatment of relapsed/refractory B-cell acute lymphoblastic leukemia.